Winslow Evans & Crocker’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$133K Buy
236
+66
+39% +$41.8K 0.03% 392
2020
Q3
$119K Sell
170
-38
-18% -$29.6K 0.03% 335
2020
Q2
$165K Hold
208
0.04% 290
2020
Q1
$126K Sell
208
-124
-37% -$121K 0.04% 295
2019
Q4
$380K Buy
332
+8
+2% +$8.7K 0.1% 205
2019
Q3
$386K Hold
324
0.11% 198
2019
Q2
$536K Buy
324
+15
+5% +$25.9K 0.15% 155
2019
Q1
$630K Hold
309
0.18% 128
2018
Q4
$398K Buy
309
+16
+5% +$24.5K 0.13% 167
2018
Q3
$556K Buy
293
+15
+5% +$31K 0.17% 138
2018
Q2
$566K Buy
278
+16
+6% +$36.5K 0.18% 130
2018
Q1
$581K Buy
262
+146
+126% +$371K 0.19% 119
2017
Q4
$267K Sell
116
-177
-60% -$359K 0.09% 219
2017
Q3
$522K Buy
293
+69
+31% +$96.4K 0.17% 132
2017
Q2
$305K Hold
224
0.08% 250
2017
Q1
$264K Sell
224
-23
-9% -$23.5K 0.08% 256
2016
Q4
$197K Buy
247
+39
+19% +$31K 0.06% 290
2016
Q3
$183K Buy
208
+131
+170% +$94.9K 0.05% 309
2016
Q2
$43.3K Hold
77
0.01% 546
2016
Q1
$42.5K Hold
77
0.01% 539
2015
Q4
$64.2K Hold
77
0.02% 485
2015
Q3
$85.5K Buy
+77
New +$140K 0.03% 408

Other funds holding BLUE

Winslow Evans & Crocker's BLUE Position: Q4 2020 in Review

Winslow Evans & Crocker increased its bluebird bio (BLUE) stake by 39% in Q4 2020, buying an estimated $41.8K and bringing the position to 236 shares worth $133K. The position accounts for 0.03% of the portfolio, ranked #392.

Winslow Evans & Crocker first reported a position in BLUE in Q3 2015 and has held it in 22 quarters since. The position peaked at $630K in Q1 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Winslow Evans & Crocker held 236 shares of bluebird bio worth $133K as of Q4 2020.
  • Winslow Evans & Crocker bought 66 bluebird bio shares in Q4 2020, an estimated $41.8K.
  • bluebird bio made up 0.03% of Winslow Evans & Crocker's portfolio in Q4 2020, its #392 holding.
  • Winslow Evans & Crocker first reported a position in bluebird bio in Q3 2015 and has held it in 22 quarters since.
  • Winslow Evans & Crocker's bluebird bio position peaked at $630K in Q1 2019.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.